@EdwardHughes:Today, we take our first in-depth look at Rubius Therapeutics which has developed a new class of cellular therapies called Red Cell Therapeutics.The company's pipeline has several candidates in development and Rubius recently addressed its current funding needs.A full investment analysis follows in the paragraphs below.